Bruker Corp (FRA:BKD)
€ 60.6 1.32 (2.23%) Market Cap: 9.12 Bil Enterprise Value: 10.17 Bil PE Ratio: 23.63 PB Ratio: 6.67 GF Score: 95/100

Bruker Corp at Jefferies London Healthcare Conference Transcript

Nov 15, 2022 / 05:00PM GMT
Release Date Price: €67 (-1.47%)
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

All right. We'll go ahead and get started. Thanks, everybody, for being here. Welcome to the Jefferies 2022 London Healthcare Conference. I'm Brandon Couillard. I cover the tools and diagnostics space. It's my great pleasure to have Bruker with us back at the conference this year here to share an update on all their progress, CFO, Gerald Herman; as well as Justin Ward, Head of IR in the audience. I will turn it over to Gerald for some prepared remarks, and then we'll jump into Q&A. Gerald?

Gerald N. Herman
Bruker Corporation - Executive VP & CFO

Well, thank you, Brandon, and it's great to be here. This is my third year, and it seems busier than ever, I would say, this year. So I thought we'd start just with a little bit of background on Bruker. I'll pass over the safe harbor materials that's -- my colleague usually reads those.

But just to give you a little bit of update on the performance, the financial performance of Bruker over the last 9 months. Some of you have been

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot